Analysed X4 PHARMACEUTICALS INC (XFOR:NASDAQ) News Sources
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01-04-2026
yahoo.com
X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
17-03-2026
yahoo.com
X4 Pharmaceuticals, Immuneering and Tango Therapeutics Are Getting New Analyst Attention
09-03-2026
247wallst.com
X4 Pharmaceuticals to Participate in a Fireside Chat at the Leerink Global Healthcare Conference
04-03-2026
yahoo.com
X4 Pharmaceuticals Receives Positive Opinion from the EMA CHMP Recommending Approval of Mavorixafor in the EU for WHIM Syndrome
27-02-2026
yahoo.com
What is the current price of X4 PHARMACEUTICALS INC (XFOR:NASDAQ)?
The current price of X4 PHARMACEUTICALS INC (XFOR:NASDAQ) is $4.17.
X4 PHARMACEUTICALS INC (XFOR:NASDAQ) absolute price change since previous trading day?
The absolute price change of X4 PHARMACEUTICALS INC (XFOR:NASDAQ) since the previous trading day is $-0.02.
X4 PHARMACEUTICALS INC (XFOR:NASDAQ) percentage price change since previous trading day?
The percentage price change of X4 PHARMACEUTICALS INC (XFOR:NASDAQ) since the previous trading day is -0.4773%.
What is the most recent average sentiment score for X4 PHARMACEUTICALS INC (XFOR:NASDAQ)?
The most recent average sentiment score for X4 PHARMACEUTICALS INC (XFOR:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for X4 PHARMACEUTICALS INC (XFOR:NASDAQ)?
The most recent sentiment for X4 PHARMACEUTICALS INC (XFOR:NASDAQ) is .
SEC-8K** Filing Available For X4 PHARMACEUTICALS INC (XFOR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.